在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

AGL Antibody, HRP conjugated

  • 中文名稱:
    AGL兔多克隆抗體, HRP偶聯
  • 貨號:
    CSB-PA001446LB01HU
  • 規格:
    ¥880
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) AGL Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    AGL
  • 別名:
    1110061O17Rik antibody; 4-1 antibody; 4-glucantransferase antibody; 6-glucosidase antibody; 9430004C13Rik antibody; 9630046L06Rik antibody; AGL antibody; AI850929 antibody; Amylo 1 6 glucosidase 4 alpha glucanotransferase antibody; Amylo-1 antibody; Amylo-alpha-1 antibody; C77197 antibody; Dextrin 6-alpha-D-glucosidase antibody; GDE antibody; GDE_HUMAN antibody; Glycogen debrancher antibody; Glycogen debranching enzyme antibody; Glycogen storage disease type III antibody; Oligo-1 antibody
  • 宿主:
    Rabbit
  • 反應種屬:
    Human
  • 免疫原:
    Recombinant Human Glycogen debranching enzyme protein (1217-1378AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    HRP
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation.
  • 基因功能參考文獻:
    1. This report of patients with GSD-III in Iran with 2 uncommon clinical presentations and 5 novel mutations in the AGL gene. PMID: 29794575
    2. The study identified 31 novel mutations and extended the mutation spectrum of AGL in Chinese patients with glycogen storage disease type III. PMID: 26984562
    3. Our study establishes HAS2-mediated HA synthesis as a driver of growth of bladder cancer with low AGL and provides preclinical rationale for personalized targeting of HAS2/HA signaling in patients with low amylo-alpha-1-6-glucosidase-4-alpha-glucanotransferase -expressing tumors. PMID: 26490312
    4. AGL loss causes high SHMT2 expression and consequently increases glycine-dependent nucleotide synthesis leading to bladder cancer growth. PMID: 26975021
    5. Point mutations in AGL gene are associated with glycogen storage disease type IIIa in a Chinese family. PMID: 26252094
    6. Haplotype analysis revealed that the mutation arises as a result of founder effect, not an independent event. PMID: 25827695
    7. AGL haplotype analyses suggested that c.1019delA and c.958+1G>A are founder mutations in Turkish patients, while p.R864X is a recurrent mutation. PMID: 25451950
    8. A homozygous frameshift deletion, c.4456delT, in exon 33 of the AGL gene in Inuit children determines the cause of glycogen storage disease type IIIa and confirms a founder effect. PMID: 25602008
    9. study identified 10 different mutations in 8 Korean Glycogen storage disease type III patients; 5 mutations are novel and include 1 nonsense (c.1461G>A, p.W487X), 3 splicing (c.293+4_293+6delAGT in IVS4, c.460+1G>T in IVS5, c.2682-8A>G in IVS21) and 1 missense mutation (c.2591G>C, p.R864P) PMID: 24257475
    10. Characterization of a novel homozygous single point mutation at the polypyrimidine tract of intron 21 of the AGL gene in two consanguineous siblings with glycogen storage disease type III. PMID: 23649758
    11. We found that most patients with macular telangiectasia-2 possess retinal autoantibodies, the most prevalent of which were directed against AGL, RBP3, and CK-B. PMID: 23882694
    12. A founder effect discovered amongst Tunisian patients with glycogen storage disease type III and a c.3216_3217delGA mutation in the AGL gene. PMID: 22035446
    13. Mutations in amylo-1,6-glucosidase is associated with Glycogen Storage Disease Type III. PMID: 20648714
    14. The present patient was found to be deficient in GDE activity and homozygous for a novel 1 bp deletion in AGL. This mutation is predicted to cause premature termination at codon 834 due to frame shift. PMID: 20158661
    15. GSD-III patients have variable phenotypic characteristics. Administration of raw-corn-starch can effectively improve the disease outcome. We identified 8 new mutations on AGL gene through nucleotide sequence analysis. PMID: 15833157
    16. Nine AGL mutations: six nonsense mutations , one deletion and two splicing mutation were identified in Turkish GSD III patients. PMID: 19834502
    17. Mutations associated with GSD III include R34X and Y1148X. PMID: 11924557
    18. it is likely that the AMPK-GDE association is a novel mechanism regulating AMPK activity and the resultant fatty acid oxidation and glucose uptake PMID: 15886229
    19. AGL gene mutations may have roles in glycogen storage disease type III PMID: 17047887
    20. These results indicate that binding to glycogen crucially regulates the stability of AGL and, further, that its ubiquitination may play an important role in the pathophysiology of both Lafora and Cori's disease. PMID: 17908927
    21. Current clinical and molecular knowledge about glycogenosis 3 and phenotype and genotype levels of this enzyme. [REVIEW] PMID: 17915576
    22. a homozygous p.W1327X mutation leads to severe generalized glycogenosis types 3a & 3b within the same family; heterozygous p.W1327X mutation carriers may present with mild non-progressive neuromuscular symptoms, such as exercise-induced myalgia & fatigue PMID: 18924225
    23. Mutations in the carbohydrate-binding domain of AGL lead to loss of all enzymatic activities and enhancing targeting for proteasomal degradation. PMID: 19299494
    24. Six novel AGL mutations were identified. PMID: 19754354

    顯示更多

    收起更多

  • 相關疾病:
    Glycogen storage disease 3 (GSD3)
  • 亞細胞定位:
    Cytoplasm. Note=Under glycogenolytic conditions localizes to the nucleus.
  • 蛋白家族:
    Glycogen debranching enzyme family
  • 組織特異性:
    Liver, kidney and lymphoblastoid cells express predominantly isoform 1; whereas muscle and heart express not only isoform 1, but also muscle-specific isoform mRNAs (isoforms 2, 3 and 4). Isoforms 5 and 6 are present in both liver and muscle.
  • 數據庫鏈接:

    HGNC: 321

    OMIM: 232400

    KEGG: hsa:178

    STRING: 9606.ENSP00000294724

    UniGene: Hs.904



主站蜘蛛池模板: 久久性色av亚洲电影| 色猫咪免费人成网站在线观看 | 夜夜躁日日躁狠狠久久av| 精品福利一区二区三区免费视频| 女的被弄到高潮娇喘喷水视频| 玩弄人妻少妇500系列网址| 精品国产久九九| 欧美肥臀大屁股magnet| 亚洲人成无码网www| 久久精品国产99精品国产2021| 日本精品一区二区三区四区| 蜜臀av色欲a片无人一区| 日本一卡2卡3卡4卡免费乱码网站| 99er热精品视频| 免费无码精品黄av电影| 成人性生交大片免费| 新版天堂资源中文www连接| 337p日本大胆欧美裸体艺术| 国产三级a三级三级| 国产欧美一区二区精品性色| 欧洲性久久精品| 2020久久天天躁狠狠躁夜夜| 大香伊人久久精品一区二区| 毛片免费视频肛交颜射免费视频 | 亚洲精品午夜理伦不卡在线观看| 国产在线精品一区二区三区 | 邻居少妇张开腿让我爽了一夜| 中文字幕无码日韩中文字幕| 精品久久久久久无码中文野结衣 | а√天堂www在线а√天堂视频 | 午夜无码国产理论在线| 国产精品特级露脸av毛片| 怡春院国产精品视频| 欧美婷婷六月丁香综合| 99er热精品视频| 免费无码国产v片在线观看| 97影院理论午夜伦不卡| 欧美性猛少妇xxxxx免费 | 国产高潮国产高潮久久久| 午夜精品久久久久久久四虎| 正在播放国产真实露脸高清|